Delivery Order SPE2DR25D9227-SPE2DR26FFLP6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/mL. The award was issued on January 29, 2026, with an ultimate completion date of January 30, 2026, under a firm fixed-price contract structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $12,468.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/ml. This firm fixed-price delivery order, issued on January 28, 2026, with an ultimate completion date of January 29, 2026, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award...
- The Defense Logistics Agency awarded a $7,481.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra Pen 30 mg/ml. The award, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award...
- The Defense Logistics Agency awarded a $29,925 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/ml. This firm fixed-price delivery order, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/mL. This firm fixed-price delivery order, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency issued a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Fasenra pen 30 mg/ml. The award, dated January 27, 2026, is firm fixed-price with an ultimate completion date of January 28, 2026, and carries no set-aside designation. DMS Pharmaceutical Group will perform at its Park Ridge facility. This delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/ml. The delivery order, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, operates under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group is performing work at its headquarters location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/mL. The award, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, utilizes firm fixed-price pricing with no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,493.75 for Fasenra Pen 30 mg/ml on January 14, 2026. This firm fixed-price delivery order, issued without set-aside designation, is funded by the Defense Logistics Agency and will be performed at the contractor's Park Ridge facility, with an ultimate completion date of January 15, 2026. The award represents a routine pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency for $14,962.50 on January 27, 2026, with an ultimate completion date of January 28, 2026. The delivery order is for Fasenra Pen 30 mg/ml, a biologic injectable medication. This award was issued without a set-aside designation, demonstrating the contractor's competitive capability in...
- SPE2DR25D9227Indefinite Delivery Contract
- SPE2DR25D9227-SPE2DR26FFLP6Delivery Order
The Defense Logistics Agency awarded a $12,468.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/ml. The award, issued on January 29, 2026, with an ultimate completion date of January 30, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9 billion acquisition strategy designed to establish multiple regional prime vendor contractors to supply comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with substantial contracting activity through the Defense Logistics Agency's Medical Supply Chain division. The company's extensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables supporting diverse therapeutic categories across military healthcare operations. The contractor's performance on numerous delivery orders and the approval as a PPV-G GEN V prime vendor through December 31, 2036, positions DMS Pharmaceutical Group to continue fulfilling the specialized pharmaceutical requirements of the Department of Defense medical system globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 1/28/26 |